Global Pharma Sales Growth Slows To Record Low Thanks To Recession – IMS
Thanks to the worsening recession, the global pharmaceutical market will experience record low sales growth of just 2.5 percent to 3.5 percent this year, or two percentage points less than forecast previously, according to a revised outlook by IMS Health
You may also be interested in...
Analyst questions whether the bone drug’s efficacy can beat Zometa’s by the necessary 15 percent.
Coupon redemptions for prescription drugs more than doubled in 2008 compared to 2007, according to a telephone and internet study of 8,700 consumers conducted by Manhattan Research, a research division of Decision Resources
Some believe unmet need refers only to rare diseases and tiny patient populations. But it is more than this. In 2020, the term sits at the heart of decision-making for drug makers – along with cost, access and value, of course.